Average Co-Inventor Count = 2.36
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Pennsylvania (9 from 2,597 patents)
2. Novartis Ag (1 from 3,923 patents)
9 patents:
1. 10357514 - Treatment of cancer using anti-CD19 Chimeric Antigen Receptor
2. 10166251 - STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases
3. 9486469 - STAT5a and its functional tumor suppressor analogs for treatment of malignancies expressing NPM/ALK and other oncogenic kinases
4. 9255279 - Anaplastic lymphoma kinase (ALK) as an oncogene capable of transforming normal human cells
5. 8778961 - O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
6. 8759370 - O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
7. 8569332 - O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
8. 7781447 - O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
9. 7754734 - O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders